OLMA logo

OLMA
Olema Pharmaceuticals Inc

1,841
Mkt Cap
$2.41B
Volume
138.00
52W High
$33.50
52W Low
$2.86
PE Ratio
-17.43
OLMA Fundamentals
Price
$31.58
Prev Close
$30.68
Open
$30.22
50D MA
$14.96
Beta
0.98
Avg. Volume
7.8M
EPS (Annual)
-$2.20
P/B
7.05
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
The Goldman Sachs Group Issues Positive Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price
The Goldman Sachs Group boosted their price objective on shares of Olema Pharmaceuticals from $26.00 to $38.00 and gave the stock a "buy" rating in a research note on Thursday...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 6% Following Analyst Upgrade
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 6% After Analyst Upgrade...
MarketBeat·18h ago
News Placeholder
HC Wainwright Raises Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $45.00
HC Wainwright raised their price target on shares of Olema Pharmaceuticals from $36.00 to $45.00 and gave the stock a "buy" rating in a research note on Thursday...
MarketBeat·21h ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Hits New 1-Year High - Here's Why
Olema Pharmaceuticals (NASDAQ:OLMA) Hits New 1-Year High - Still a Buy...
MarketBeat·2d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 7.7% - Here's Why
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 7.7% - Should You Sell...
MarketBeat·3d ago
News Placeholder
XTX Topco Ltd Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA
XTX Topco Ltd bought a new stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Reaches New 1-Year High - Here's What Happened
Olema Pharmaceuticals (NASDAQ:OLMA) Sets New 1-Year High - Should You Buy...
MarketBeat·15d ago
News Placeholder
15,000 Shares in Olema Pharmaceuticals, Inc. $OLMA Bought by Titleist Asset Management LLC
Titleist Asset Management LLC acquired a new stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities...
MarketBeat·16d ago
News Placeholder
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nine research firms that are presently covering the firm...
MarketBeat·19d ago
News Placeholder
The Goldman Sachs Group Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $26.00
The Goldman Sachs Group increased their price target on Olema Pharmaceuticals from $18.00 to $26.00 and gave the company a "buy" rating in a report on Friday...
MarketBeat·20d ago

Latest OLMA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.